申请人:NewThera
公开号:EP1752143A1
公开(公告)日:2007-02-14
The present invention relates to novel therapeutic uses of tianeptine, salts, isomers, prodrugs, metabolites and structural analogs thereof. Furthermore, the present invention relates to the use of tianeptine, salts, isomers, pro-drugs, metabolites and structural analogs thereof, in obtaining methods of screening and of developing drugs. Finally, the present invention relates to the novel therapeutic use of other glutamine synthetase (GS) ligands and to the use of these ligands in obtaining methods for screening and developing drugs.
本发明涉及噻奈普汀、其盐类、异构体、原药、代谢物和结构类似物的新型治疗用途。此外,本发明还涉及噻奈普汀、其盐类、异构体、原药、代谢物和结构类似物在获得药物筛选和开发方法中的用途。最后,本发明涉及其他谷氨酰胺合成酶(GS)配体的新型治疗用途,以及使用这些配体获得筛选和开发药物的方法。